Inside Tandem’s Latest: catching up with VP of Product Management Marisa Fienup

We’ve got an update from Tandem Diabetes. We’re talking about Libre 3 plus integration, Lyumjev approval, Mobi tubeless, extended wear infusion sets and a lot more with VP of Product Management Marisa Fienup. She’s also answering your questions about tubing, alerts, and shares what’s next. This podcast is not intended as medical advice. If you…

“And Now a Word from Our Community!”

“…and now a word from our community!” It’s Diabetes Awareness Month and this year, I want to try something new. For nearly ten years, Diabetes Connections has amplified stories, innovations, and voices from across the diabetes community. Now, I want to turn the mic over to you. We’re launching Community Commercials: short messages from our listeners…

What Extreme Adventures Can Teach Us About “Ordinary” Life with T1D, with Patrick Mertes

What can those of us who will never climb the highest mountains, or take on extreme outdoor challenges – learn from those who do? Patrick Mertes and Michael Shelver have hiked and biked – and fallen – on incredible expeditions, while living with type 1. They’ll share what they’ve learned, how those lessons apply to…

A new resource for exercise and T1D: DiabetesWise wants to help you move with confidence

We all know how important exercise is for good health. And we all know how difficult exercise can be with type 1 diabetes. There’s a new resource from some of the smartest people in our community. The folks at Diabetes Wise are adding exercise to their platform, which already has community and expert sourced information…

In the News.. COVID-19 & T1D, Ozempic Pill Progress, FDA to Consider Afrezza for kids, Faster Insulin, “Beyond Misconceptions,” and More

n the News.. COVID-19 & T1D, Ozempic Pill Progress, Faster Insulin, “Beyond Misconceptions,” and More It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: A new study looks at the link between COVID-19 and very young children, Lilly moves ahead with their Ozempic oral…

“I’m excited for less work for the person with diabetes” – An update from Medtronic’s Dr. Jennifer McVean

This week on Diabetes Connections.. Medtronic is making some big moves.. from new sensors, to spinning off the diabetes division.  Dr. Jen McVean, medical affairs director at Medtronic’s diabetes business. Dr. McVean lives with type 1 and has a real passion for better access and better outcomes using technology. We talk about their latest real-world…

In the News.. Insulin pricing, oral pill for T1D prevention studied, false low A1Cs, MedT’s new sensor, and more!

It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out…